NCT05823584View on ClinicalTrials.gov

Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence

CompletedOBSERVATIONAL

Enrollment

207

Participants

Timeline

Start Date

December 22, 2019

Primary Completion Date

July 21, 2023

Study Completion Date

December 31, 2023

Conditions

Hepatocellular Carcinoma

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors

collaborator

National Taiwan University Hospital

OTHER

lead

TCM Biotech International Corp.

INDUSTRY

NCT05823584 - Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence | Biotech Hunter | Biotech Hunter